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The simultaneous demonstration of three surface antigens of 
Langerhans cells (LC) within LC-enriched fresh epidermal 
cell suspensions from normal human skin was achieved , by 
m eans of a triple immunogold (I G) staining, using commer-
cially available monoclonal antibodies (moAb) and immu-
noreagents, in a simple pre-embedding immunoelectronmi-
croscopy (IEM) procedure . As a result, suspended LC were 
triple-stained as follows: gold particles of 40 nm revealed the 
C Dla antigen; gold particles of 20 nm revealed the HLA-
DR antigen; and gold particles of 5 nm revealed the CD4 
anti gen. All the observed epidermal Birbeck granule-bearing 
LC were tripl e IG stained, thus simultaneously expressing 
the three surface differentiation antigens, which are there-
fore different from but coexisting with each other. 
L angerhans cell s (LC) are fascinating, bone marrow-de-rived [1] , dendritic epidermal cells which display a criti-cal rol e in the immunologic fun ctions of the skin . The phenotypic profile of the LC membrane includes, to-gether with the receptors for Fc-IgG and complement 
[2], a number of increasingly investi gated surface antigens. The 
o ccurrence of at least three such anti gens is now well established; 
n a mely, the HLA-DR antigen [3 ,4]' the CDl a anti gen [5 ,6] , and 
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PBS: phosphate-buffered sa line 
RPMI-FCS: RPMI-1640 with 10% FCS 
The present investigation assesses the constant simulta-
neous expression by Birbeck granules bearing LC of not only 
CDla and HLA-DR antigens, but also C D4 antigen. T he 
occurrence is therefore excluded of both CD l a-positive, 
HLA-DR-negative LC subpopulation and C D4-negative LC 
subpopulation, presumably due to the different sensitivity of 
the various procedures performed. The hypothetical occur-
rence of C D4-positive, CDla-, and/or H LA-DR-negative 
LC subpopulations is ruled out. This study reaffirms indeed 
the high specificity and sensitivi ty of the IG-IEM method for 
a precise detection of the cell surface antigens of LC, and 
states the suitability of the IG labeling even for accurate 
multiple IEM stainings ofLC.] b west Dermato/ 91 :547 -552, 
1988 
the CD4 anti gen [7] , together with other antigens somehow related 
to them, such as HLA-DP, HLA-DQ [8], and C D1 c [9]. 
However, evidence indicates striking heterogeneities regard ing 
the expression of such three anti gens on LC, thus suggesting the 
existence of distinct subsets of LC. In fac t, CD1a-positive cells 
seemed more numerous than HLA-DR-positiue cells [10 - 14]. T his 
observation is in contras t to othecreports [1 5 - 19]. Although the 
CD4 expression 0 11 LC was noticed by some authors [7,20,21]' 
several papers seemingly demonstrated CD4 negativity of ei ther all 
LC [22 - 24], or of at least a percentage [1 4,25]. A major drawback in 
such investi gations, however, was the demonstration of only one or, 
at the most, two surface antigens of LC per experiment. T he first 
simultaneous detection of two different surface antigens on LC by 
ultras tructural immuno-gold (IG) labeling was achieved in 1985 
[1 8]. However, a single LC had never been triple labeled to detect 
the C D 1 a, H LA-DR, and CD4 antigens simultaneously. Moreover, 
a number of such investigations were performed by merely immu-
nohistologic methods in li ght microscopy (LM), which alone can-
not ensure an accurate identification of LC. In fac t , because thcsc 
threc anti gcns can bc expresscd not only by LC but also by other 
cells of the monocyte/histiocyte and/or lymphocyte series [7, 26 -
33], the precise identification of LC rests on the electron micros-
copy (EM) demonstration of distinctive ultrastructura l charactcris-
tics , including Birbcck granul es [34]. The present investi gation 
empl oys a tripl e IG staining mcthod in pre-cmbedding immunoe-
lcctronmicroscopy (I EM) to assess simultaneously the expression of 
thrce surface antigens on human freshly suspcnded epidermal cells 
(EC). It was thus possible to demonstrate that all the observed Bir-
beck granule-bea ring LC simultaneously showcd the anti-HLA-
D R, the anti-C D la , and the anti-CD4 reactivities. 
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Table I. Primary Monoclonal Antibodies, Secondary Immunoreagents, and Control Antibodies and Reagents Used in the Present Study 
moAb Specificity 
No. Reagent Isotype Source Dilution Buffer (Reference) 
1. Anti-Leu-6 (COla) moAb 
2. Biotinylated anti-HLA-DR moAb 
3. Anti-CD4 moAb, 5 nm gold-coupled 
4. Goat anti-mouse Ab, 40 nm gold-coupled 
5. Streptavidin, 20 nm gold coupled 
6. Mouse unreactive fraction 
7. Goat anti-mouse Ab 
8. Anti-HLA-DR moAb 
9. Streptavidin 
10. Anti-Leu-3a + anti-Leu-3b (CD4) moAb 
11. Mouse unreactive fraction 
12. Mouse biotynylated unreactive fraction 
13. Anti-Epstein Barr virus moAb,S nm gold coupled 
14. 40 nm gold particles 
15. 20 nm gold particles 
16. 5 nm gold particles 
, Becton Dickinson Monoclonal Center (Mountain View, CAl 
b E-Y Laboratories, Inc. (San Mateo, CAl 
, Janssen Pharmaceutica (Beerse, Belgium) 
d Pel-Freez Biologicals (Rogers, AZ) 
, C hemicoll International Inc. (EI Segundo, CAl 
(Bethesda Research Laboratories, Inc. (Gaithersburg, MA) 
• Eurobio (Paris, France) 
h Ortho Pharmaceutical Co (Raritan, N J) 
MATERIALS AND METHODS 
IgG2b 
IgG2a 
IgGl 
IgG 
IgG 
IgG 
IgG2a 
IgG1 
IgG2b 
IgG 
IgGI 
Normal Human Skin Normal human skin was obtained from 
ten healthy subjects, whose age ranged from 21 to 58 years. The 
skin was removed from either abdomen or breast areas, by means of 
plastic surgery reduction operations. 
Antibodies and Immunoreagents The primary monoclonal an-
tibodies (moAb), the secondary antibodies and "immunoreagents, 
and the control immunoreagents employed in the present investiga-
tion are listed in Table 1. 
Media and Chemicals The vast majority of immunoreagents 
were diluted in phosphate-buffered saline (PBS) with bovine serum 
albumin (BSA) (Sigma Chemical Co., St. Louis, MO, PBS-BSA), 
pH 7.2, at the dilutions listed in Tables I and II. BS~ buffer, used as 
indicated (Tables I and II), dealt w ith 0.05 M Tns sal1ne buffer 
containing BSA and 0.02 M sodium azide, pH 8.2. Trypsin, Hanks' 
balanced salt solution (HBSS), RPMI-1640 medium, and heat-inac-
tivated fetal calf serum (FCS) were from Gibco (Paisley, Scotland). 
Ficoll-Hypaque was purchased from Pharmacia Fine Chemicals 
(Uppsala, Sweden) . 
Table II. Protocol for the Immunogold Triple Labeling of 
LC-enriched EC Suspensions 
Steps 
1. First incubation: anti-COla moAb 
2. Washes in PBS-O.l % BSA 
3. Washes in 0.1 % BSA buffer 
4. Second incubation: 40 nm gold-coupled goat anti-mouse 
IgG 
5. Washes in 0.1 % BSA buffer 
6. Washes in PBS-O.l % BSA 
7. Third incubation: mouse unreactive IgG fraction 
8. Washes in PBS-0.1 % BSA 
9. Fourth incubation: biotinylated anti-HLA-DR moAb 
10. Washes in PBS-O.t % BSA 
11. Fifth incubation: 20 nm gold-coupled streptavidin 
12. Washes in PBS-O.l % BSA 
13. Sixth incubation: 5 nm-gold coupled anti-CD4 moAb 
14. Washes in PBS-O.l % BSA 
Time 
20 min 
10min 
5 min 
30 min 
5 min 
10 min 
20 min 
10 min 
20 min 
10 min 
30min 
to min 
30 min 
10 min 
B-D (a) 
B-D (a) 
E-Y (b) 
Janssen (c) 
E-Y (b) 
Pel-Freez (d) 
Chemicon (e) 
B-D (a) 
BRL (f) 
B-D (a) 
Chemicon (e) 
Eurobio (g) 
E-Y (b) 
Ortho (h) 
Ortho (h) 
Ortho (h) 
1 : 40 
1:40 
1:40 
1: 10 
1:10 
1:2 
1 : 10 
1:40 
1: 10 
1:40 
1:40 
1: 40 
1: 40 
1: 10 
1:10 
1:40 
PBS-1% BSA 
PBS-l % BSA 
PBS-l % BSA 
1 % BSA buffer 
PBS-1 % BSA 
PBS-O. 1 % BSA 
PBS-O. 1 % BSA 
PBS-l % BSA 
PBS-O.l % BSA 
PBS-1 % BSA 
PBS-l% BSA 
PBS-l % BSA 
PBS-1 % BSA 
1 % BSA buffer 
PBS-1 % BSA 
PBS-l % BSA 
5,6,33 
3,4,26-29 
7,30-32 
3,4,26-29 
7,31, 32 
For ultrastructural studies, Bacto-Agar was from Difco Laborato. 
ries, (Detroit, MI) and Durcupan ACM was purchased by Flub 
(Buchs, Switzerland). 
Preparation and LC Enrichment of Epidermal Cell Suspen_ 
sions The LC isolation and enrichment were carried out slightly 
modifying a method previously described [18). Briefly, the normal 
human skin was trimmed and subsequently split-cut by means of a 
keratotome, set at 0.4 mm. The freshly removed slices were treated, 
dermal side down, with 0.25% trypsin in HESS, for 1 h at 37°C. 
After the separation of the epidermis from the dermis, the isolated 
epidermal sheets were pooled in HBSS supplemented with 10% 
FCS, and subsequently were shaken and vigorously pipetted for 
2 - 5 min. After filtration, the suspended cells were sedimented by 
centrifugation at 400 g for 10 min. The collected cells were then 
resuspended in RPMI-1640 with 10% FCS (RPMI-FCS). After two 
washings in RPMI-FCS, the viability, assessed by eosin excl usion, 
was higher than 80%. 
The LC enrichment was obtained by Ficoll-Hypaque gradient 
sedimentation, by a centrifugation at 400 g for 10 min of the 
RPMI-FCS suspended EC. The cell s at the interface were then 
coll ected and resuspended in RPMI-FCS. The estimated viability of 
such LC-enriched EC was higher than 90%. The percentage ofLC 
enrichment was approximately 15%. 
Triple IG Staining Protocol The triple IG labeling of the LC-
enriched EC suspensions was carried out slightly modifying the 
protocol described by us for the triple IG staining of peripheral 
blood mononuclear cells (submitted for publication). Briefly, EC 
(5 X 106/ml) were first pefixed with 0.1 % g lutara ldehyde in 0.1 M 
cacodylate buffer (pH 7.4) for 10 min. After quenching aldehyde 
groups by 50 mM g lycine, and washings in PBS-0.1 % BSA (pH 
7.2), the EC suspension was rinsed in a blocking solution, including 
PBS-1 % BSA, 0.2% sodium azide, and 10% human AD serum, for 
30 min. After washings in PBS-0.1 % ESA (pH 7 .2) the triple label-
ing protocol was applied by a six-steps procedure as indicated in 
Table II. Therefore, the CD1a antigens were revealed by a rwo-
steps (indirect) method (first and second incubations), stained by the 
40 nm go ld particles. After a blocking step (third incubation), the 
HLA-DR antigens were revealed by another two-steps (biotin-avi-
din) method (fourth and fifth incubations), obtained by the 20 nm 
gold particles. The CD4 antigen was finally revealed by a one-step 
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Figure 1. Immunoelectronmicrographs showing 
su spended epidermal ce lls. investigated by the triple 
immunogold stainin g method. A: Three suspended 
epidermal cells are shown, including two negative 
keratinocytes (K) and one triple labeled Langerhans 
cell (Le). The rectangulated area is considered, en-
larged. in B . Bar: 1/1m. B: The triple labeled Langer-
hans cell shows, although faintly visible at this magni-
fication , gold granules of different sizes along its 
plasma membrane. while the plasma membranes of the 
faci ng kcratinocytes are absolutely negative. The 
arrolVS indicate Birbeck granules within the cytoplasm 
of the Langerhans cel l. A high magnification of the 
rectangulated area is considered in C. Bar: 1/1m. C: At 
this magnification even the 5-nm gold particles arc 
well visible. The CO l a antigens arc detected by the 40 
nm particles, the HLA-OR antigens are detected by 
the 20-nm particles. and the C04 antigens are de-
tected by the 5-nm particles. Bar: 0.2/1m. 
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(direct) method (sixth incubation), stained by the 5 nm gold parti-
cl es (Table II). After the triple immunogold staining procedure, the 
EC suspension was was hed in PBS (pH 7.2) for 20 min. 
Electron Microscopy (EM) After fixation in 1 % glutaraldehyde 
in 0.1 M cacodylate buffer (pH 7.4) EC suspension was embedded 
in 2% Bacto-Agar at 45 °C, postfixed in osmium tetroxide reduced 
by potassium ferryci anide, dehydrated in aceton, embedded in Our-
cupan ACM, sectioned by a LKB III ultramicrotome, and examined 
at a Philips EM 300 electron microscope. 
Positive Controls Controls for immunoreagents consisted of 
staining peripheral blood mononuclear cells from healthy donors to 
show the HLA-OR positivity ofB lymphocytes [26,27] and mono-
cytes [28,29J by the two-steps (biotin-avidin) method, and the C04 
positivity of a subset of T lymphocytes [30 - 32] by the one-step 
(direct) method. Hairy cell leukemia cell s from two patients served 
as positive control for the COla positivity by the two-steps (indi-
rect) method, because such cel ls are even anti-COla-reactive, as 
recently shown by us [33]. 
Negative Controls Four kinds of controls for the triple staining 
specificity were carried out: 1) inhibition of the labeling by preincu-
bation, before the four labeled immunoreagents, with the unlabeled 
immunoreagents of the same isotype (Table I, immunoreagents no. 
7, 8, 9, and 10); 2) substitution of the three moAb with mouse 
unreactive fractions or with non-sense moAb of the same isotype 
(Table I, immunoreagents no. 11, 12, and 13); 3) substitution of the 
anti-CO 1a and of the biotinylated anti-HLA-OR moAb with buffer 
solutions; 4) use of uncoupl ed gold particles of the same size (Table 
I, reagents no. 14, 15, and 16) instead of the gold-coupled immu-
noreagents. 
RESULTS 
Analysis of the Colloidal Gold Staining The triple labeled 
cells were identified because electron-dense gold granu les of three 
different s~zes were observed, although in low density, along the 
cell surface (Figs 1 and 2). In fact, single gold particles or, at most, 
very small clusters of gold particles of the same size were detected 
random ly scattered along the plasma membrane (Figs Ib, c and 2a, 
c), without consistent interferences between gold particles of differ-
ent sizes. No gold particles were usually observed within the cyto-
plasm. 
Triple Labeled Langerhans Cells Approximately 300 tripl e la-
beled LC with Birbeck granules from 10 samples were observed. All 
the Birbeck granule-bearing (Figs 1 b, 2b) LC were triple IG stained 
(Figs 1c and 2c). The detection of 40-nm gold particles revealed the 
COla antigen; the detection of 20-nm go ld particles revealed the 
HLA-OR anti gen; and the detection of 5 nm gold particles revealed 
the C04 antigen (Figs lc, 2c). A heterogeneity in HLA-OR antigen 
density on LC, similar to that previously reported [35], was ob-
served. 
Control Experiments Controls for immunoreagents, performed 
on peripheral blood mononuclear cells and on hairy cell leukemia 
cells, proved positive. T he four types of controls for the triple stain-
ing specificity all proved negative. 
DISCUSSION 
In the present investigation, a simple triple IG technique developed 
in IEM was applied to the simultaneous detection of three surface 
antigens of fresh ly suspended Ee. Colloidal gold was chosen as 
electron-dense marker, due to a number of advantages in compari-
son to other !EM markers, such as peroxidase [36J and ferritin [37J. 
Further, colloida l gold all ows accurate identification of labeled 
structures not only by single labelings and double labelings, but 
even by triple labeling IEM systems [38,39]. Indeed, we succeeded 
in demonstrating at the ultrastructural level three surface antigens 
on single LC; namely, the CDla, HLA-DR, and CD4 antigens, 
detecting colloidal gold particles of 40,20, and 5 nm, respectively . 
The three types of gold granul es, simultaneously mapped, were 
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spatially separated, thus demonstrating that the three antigens have 
a different topographic distribution [38J on the surface of freshly 
isolated, gl utaraldehyde prefixed, LC. However, the prefixation by 
glutaraldehyde decreases the accessible antigenic sites and explains 
the low density of gold gran ules fixed on the LC membrane. A 
higher number of gold granules could be obtained with prefixation 
using paraform.aldehyde at low concentration, or by immunolabe l_ 
ing on living cell s before fixation; ultrastructural details, however, 
are better preserved after glutara ldehyde fixation. 
T he present results demonstrate tbat all the Birbeck granule_ 
bearing EC were triple stained, thus simultaneously expressing the 
three antigens; namely, COla, HLA-OR, and C04. This finding 
seems in contrast to those reports claiming that three such antigens 
are heterogeneously distributed in LC population in normal epi-
dermis, as mentioned above [10 - 14, 22-25J. However, it is OUr 
opinion that these apparent discrepancies could be well explained 
both by the different sensitivi ty of the methods used and by the 
different quantitative expression of the three antigens on the LC 
surface. In fact, most of the above-mentioned investigations dealt 
with in situ labelings of skin sections in LM, which are clearly less 
sensitive compared with IG methods detecting in IEM surface-asso-
ciated antigens of LC, both on skin sections [40J and especially on 
suspended EC [20,35]. Indeed, when the highly sensitive double 
labeling IG method in IEM was performed, all the Birbeck granule_ 
containing LC bound simultaneously both the anti-CO la and the 
anti-HLA-OR moAb [18 ,19J. Further, even different but sensitive 
enough techniques on EC suspensions yielded numbers approxi-
mately equal of HLA-OR- and COla-positive LC, respectively 
[15 - 17J. The fact that only a subset of COla-posi tive LC were 
apparently found HLA-OR positive in some in situ investigations 
[10 - 14] might be addressed keeping in mind that Birbeck granule-
bearing LC include cells showing either strong or weak HLA-OR 
expression [35] . Indeed, a percentage of the very weakly HLA-OR-
expressin g LC might escape the it:nmunocytochemical detection 
when the revealing methods are not highly sensitive. Conversely, 
all the HLA-OR-expressing LC, including the very weakly ex-
pressing ones, are detected [18,19 ,35J by highly sensitive tech-
niques, such as the IG-IEM procedure. 
Similarly, the IG-IEM procedure was undoubtedly able to dem-
onstrate the anti-C04 reactivity of LC [20]. Further, even the indi-
rect immunofluorescent technique, both in situ and by the fluores-
cence-activated cel l sorter analysis, also showed the C04 reactivity 
ofLC [7] . When techniques of different sensitivity were used, even 
by the same authors, the number of the C04-positive LC was more 
and more near that of COla-positive LC, while the sensitivity of 
the methods increased; namely, from one-step or two-steps 
methods on cryostat sections, to four-steps method on cryostat sec-
tions, to epidermal sheet preparations, to in situ IEM [21]. This 
implies that on ly limited amounts of C04 molecules are presum-
ably present on LC of normal human epidermis in comparison to 
the higher amounts of COla moieties [7,20,21]. 
In add ition , a sure anti-C04 reactivity of normal resting LC 
seems to also be demonstrated both by recent functional investiga-
tions, and by studies on affected skin. In fact, the presumably weak 
C04 antigenic expression on control LC seemingly increased both 
after incubation with gamma-interferon [25J and in affected skin 
[7,21,22-24J as compared to normal skin. Before incubation with 
gamma-interferon, the density of C04-positive LC in gingival epi-
thelium, as detected by an immunoperoxidase method in LM, ap-
parently was merely 12.7% of the density of COla-positive LC, 
while after gamma-interferon 100% LC were C04-positive [25J, 
presumably because the method was not sensitive enough to reveal 
the weak C04 expression of many resting LC. Gamma-interferon, 
enhancing such C04 expression, made all the LC detectable even 
by that method. C04-positive LC were visualized at the threshold 
of detectability in normal human skin, while strong and prominent 
C04 positivity of LC was encountered in cutaneous T-cell lym-
phoma and various inflammatory conditions, even by using the 
same investigating techniques used for the normal skin [21 J. Inter-
estingly, some methods unable to detect C04 expression on LC in 
normal epidermis did allow the detection of the C04 expression on 
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Figure 2. Immunoelectronmicrographs showing a t riple il11l11unogold labeled Langerhans cel l. A : A portion of a tr iple sta ined Langerhans cell is visible. 
B oxes indicate the areas shown in Band C. Bar: 0.2 J.l111 . B: Several Birbeck granules are visible within the cytoplas l11 of the t ri ple stained Langerhans cell. Bar: 
0 . 1 J.l111 . C: At high l11agnification, three types of granules are well visible along the plasma membrane of the Langerhans cel l. T he 40-nm granule indicates 
the presence of the C Ol a antigen, and the 20-nm granule indicates the pesence of the HLA-DR antigen , w hile the 5-nl11 granule indicates the presence of the 
CD4 antigen. Bar: 0.1 Ill11 . 
h istiocytosis X cells (22-24), whereas other methods allowed the 
de monstration of C D4 both on LC and on histiocytosis X cells (7). 
It can therefore be assumed that the whole human normal resting 
LC population expresses the C D4 antigen, although such an ex-
pression is better revealed by most sensitive immunostaillillg 
m eth ods; this was the case of the present technique, due to both the 
high sensitivi ty of the IG-IEM procedure [20] and the good accessi-
bility of thc gold-coupled anti-CD4 moAb, favored by the small 
size (5 nm) of the gold particles [38). 
The present findin gs extend the analysis yielded on the CD4-pos-
itivity ofLC in previous investigations. After the initial demonstra-
tion of the LC reactivity with OKT4 [7] , all th e OKT4-positive EC 
were shown to be Birbeck granul es-bearing LC [20), and the LC (or 
at least a subpopulation thereof) were shown as the only resident Ee 
to react with moAb agai nst the CD4 antigen [21) . However, the 
question ~as ra ised of the hypothetical occurrence of either a) a 
C D4-negative LC subpopul ation, or b) CD4-positive but CDta 
and/or HLA-DR-negativc LC subpopulations. To address these 
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questions, we therefore carried out a triple labeling on EC to simul-
taneously reveal the CDla, HLA-DR, and CD4 antigens. Because 
this triple IG-IEM investigation showed that all the Birbeck-gran-
ule positive LC always express not only the CDla and HLA-DR 
antigens, but even the CD4 antigen, the evidence of a) a CD4-nega-
tive LC subpopulation and of b) CD4-positive, CDla-, and/or 
HLA-DR-negative LC subpopulations can both be excluded in nor-
mal human skin. In conclusion, the data presented here definitely 
assess the constant CD4 expression by LC of normal human epi-
dermis. 
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